Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Why is Shenzhen Mindray Bio-Medical Electronics Co., Ltd. ?

The company has declared Negative results for the last 3 consecutive quarters

NET PROFIT(HY) At CNY 4,940.88 MM has Grown at -33.91%
OPERATING CASH FLOW(Y) Lowest at CNY 8,641.15 MM
NET SALES(HY) At CNY 17,395.34 MM has Grown at -12.58%

With ROE of 24.07%, it has a expensive valuation with a 7.41 Price to Book Value

Over the past year, while the stock has generated a return of -31.14%, its profits have fallen by -25.2%
At the current price, the company has a high dividend yield of 2.1

Below par performance in long term as well as near term

Along with generating -31.14% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shenzhen Mindray Bio-Medical Electronics Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

-30.82%

-1.84

24.37%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

10.29%

EBIT Growth (5y)

5.50%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.46

Sales to Capital Employed (avg)

0.94

Tax Ratio

9.95%

Dividend Payout Ratio

65.07%

Pledged Shares

Institutional Holding

0.02%

ROCE (avg)

76.50%

ROE (avg)

29.93%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

7.41

EV to EBIT

29.42

EV to EBITDA

24.87

EV to Capital Employed

12.33

EV to Sales

8.36

PEG Ratio

Dividend Yield

2.07%

ROCE (Latest)

41.92%

ROE (Latest)

24.07%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -7.37% (YoY

NET SALES(Q)

Highest at CNY 8,985.81 MM

-26What is not working for the Company

NET PROFIT(HY)

At CNY 4,940.88 MM has Grown at -33.91%

OPERATING CASH FLOW(Y)

Lowest at CNY 8,641.15 MM

NET SALES(HY)

At CNY 17,395.34 MM has Grown at -12.58%

ROCE(HY)

Lowest at 22.52%

DEBT-EQUITY RATIO (HY)

Highest at -43.66 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.78 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 8.34 times

INTEREST(Q)

Highest at CNY 6.45 MM

Here's what is working for Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Net Sales

Highest at CNY 8,985.81 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Raw Material Cost

Fallen by -7.37% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Net Profit

At CNY 4,940.88 MM has Grown at -33.91%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

At CNY 6.45 MM has Grown at 21.43%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY 8,641.15 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

Highest at CNY 6.45 MM

in the last five periods and Increased by 21.43% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at -43.66 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 2.78 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 8.34 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio